Absorption | ||||
---|---|---|---|---|
Parameters | Value | Probability | Finding | |
Human intestinal absorption (HIA) | + | 0.9924 | Yes | |
Human oral bioavailability (HOB) | - | 0.7714 | No | |
Caco-2 permeability | + | 0.5943 | Yes | |
Log Kp (skin permeation) | - | -6.14 cm/s | - | |
Distribution | ||||
 Blood-brain barrier penetration (BBB) | + | 0.7879 | Yes | |
 Estrogen receptor binding (ERB) | + | 0.8332 | Yes | |
 Androgen receptor binding (ARB) | - | 0.5000 | No | |
 P-glycoprotein substrate | + | 0.5562 | Yes | |
 P-glycoprotein inhibitor | - | 0.8934 | No | |
 Plasma protein binding (PPB) | 0.857 | 100% | Yes | |
Metabolism | ||||
 Cytochrome P450 (CYP450) | CYP3A4 substrate | + | 0.5566 | Yes |
CYP3A4 inhibition | - | 0.5902 | No | |
CYP2C9 substrate | - | 0.7974 | No | |
CYP2C9 inhibition | - | 0.8278 | No | |
CYP2D6 substrate | + | 0.3792 | Yes | |
CYP2D6 inhibition | - | 0.7926 | No | |
 Pharmacokinetics transporters | OATP1B1 inhibitor | + | 0.8982 | Yes |
 | OATP1B3 inhibitor | + | 0.9091 | Yes |
 | BSEP inhibitor | + | 0.7452 | Yes |
Excretion and Toxicity | ||||
 Organ toxicity | Human either-a-go-go-ralted gene (hERG) inhibition | + | 0.7369 | Yes |
Acute oral toxicity | 2.29 | kg/mol | - | |
 Genomic toxicity | Ames mutagenesis | - | 0.5700 | No |
Carcinogenicity (binary) | - | 0.7000 | No | |
Carcinogenicity (trinary) | Non-required | 0.7188 | No | |
 Eco-toxicity | Crustacea aquatic toxicity | - | 0.5185 | No |
Biodegradation | - | 0.6250 | No | |
Hepatotoxicity | - | 0.8000 | No | |
 | Eye corrosion | - | 0.9803 | No |
 | Eye irritation | + | 0.9328 | Yes |
 | Honeybee toxicity | + | 0.7611 | Yes |
 | Fish aquatic toxicity | - | 0.9799 | Yes |
 | Tetrahymena Pyriformis | 0.888 | pIGC50 (ug/L) | - |